Allianz Asset Management Gmb H Immuno Gen, Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$12.46 - $29.95 $2.12 Million - $5.08 Million	169,750 Added 380.61%	214,350 $6.36 Million
Q3 2023 Nov 13, 2023	SELL	$14.09 - $19.87 $138,082 - $194,726	-9,800 Reduced 18.01%	44,600 $707,000
Q2 2023 Aug 11, 2023	BUY	$3.75 - $20.05 $158,250 - $846,110	42,200 Added 345.9%	54,400 $1.03 Million
Q1 2023 May 11, 2023	SELL	$3.67 - $4.92 $183,500 - $246,000	-50,000 Reduced 80.39%	12,200 $46,000
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $163,800 - $227,160	-36,000 Reduced 36.66%	62,200 $308,000
Q3 2022 Nov 08, 2022	SELL	$4.48 - $6.47 $1.44 Million - $2.08 Million	-322,120 Reduced 76.64%	98,200 $469,000
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $693,582 - $1.27 Million	220,185 Added 110.02%	420,320 $1.89 Million
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $88,437 - $155,284	-20,760 Reduced 9.4%	200,135 $952,000
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $755,273 - $1.19 Million	159,005 Added 256.92%	220,895 $1.64 Million
Q3 2021 Nov 10, 2021	SELL	$5.02 - $6.59 $770,946 - $1.01 Million	-153,575 Reduced 71.28%	61,890 $351,000
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $1.03 Million - $1.53 Million	-177,775 Reduced 45.21%	215,465 $1.42 Million
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $676,162 - $1.1 Million	-104,025 Reduced 20.92%	393,240 $3.19 Million
Q4 2020 Feb 16, 2021	SELL	$3.7 - $7.66 $1.07 Million - $2.21 Million	-288,181 Reduced 36.69%	497,265 $3.21 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $43,035 - $60,997	-12,474 Reduced 1.56%	785,446 $2.83 Million
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $1.51 Million - $2.42 Million	453,894 Added 131.94%	797,920 $3.67 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $729,335 - $2.34 Million	344,026 New	344,026 $1.17 Million
Q2 2019 Aug 08, 2019	SELL	$1.8 - $3.3 $166,485 - $305,223	-92,492 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$2.41 - $5.91 $222,905 - $546,627	92,492 New	92,492 $251,000
Q4 2018 Feb 14, 2019	SELL	$3.94 - $9.7 $1.87 Million - $4.6 Million	-473,846 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$8.6 - $11.26 $2.47 Million - $3.23 Million	-286,941 Reduced 37.72%	473,846 $4.49 Million
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $3.68 Million - $4.7 Million	386,834 Added 103.44%	760,787 $7.4 Million
Q1 2018 May 14, 2018	BUY	$6.7 - $12.95 $966,548 - $1.87 Million	144,261 Added 62.81%	373,953 $3.93 Million
Q4 2017 Feb 13, 2018	SELL	$5.07 - $7.92 $14,921 - $23,308	-2,943 Reduced 1.27%	229,692 $1.47 Million
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $1.26 Million - $1.97 Million	232,635	232,635 $1.78 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account